CIBC World Market’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.75M | Sell |
30,068
-3,102
| -9% | -$773K | 0.01% | 492 |
|
|
2025
Q4 | $7.99M | Sell |
33,170
-8,768
| -21% | -$2.24M | 0.01% | 472 |
|
|
2025
Q3 | $11.5M | Sell |
41,938
-1,527
| -4% | -$417K | 0.02% | 381 |
|
|
2025
Q2 | $11.2M | Buy |
43,465
+10,580
| +32% | +$2.52M | 0.02% | 355 |
|
|
2025
Q1 | $7.36M | Sell |
32,885
-20,296
| -38% | -$4.74M | 0.02% | 414 |
|
|
2024
Q4 | $12.2M | Buy |
53,181
+18,159
| +52% | +$4.37M | 0.03% | 299 |
|
|
2024
Q3 | $8.55M | Buy |
35,022
+17,426
| +99% | +$3.89M | 0.02% | 360 |
|
|
2024
Q2 | $3.37M | Buy |
17,596
+15,489
| +735% | +$3.14M | 0.01% | 534 |
|
|
2024
Q1 | $417K | Buy |
+2,107
| New | +$386K | ﹤0.01% | 1039 |
|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$243K | – | 1352 |
|
|
2022
Q1 | $243K | Buy |
1,000
+115
| +13% | +$27.8K | ﹤0.01% | 1143 |
|
|
2021
Q4 | $231K | Sell |
885
-39
| -4% | -$10.1K | ﹤0.01% | 1208 |
|
|
2021
Q3 | $244K | Buy |
924
+19
| +2% | +$5.2K | ﹤0.01% | 1194 |
|
|
2021
Q2 | $223K | Buy |
+905
| New | +$190K | ﹤0.01% | 1231 |
|
|
2020
Q4 | – | Sell |
-2,850
| Closed | -$489K | – | 1322 |
|
|
2020
Q3 | $489K | Sell |
2,850
-278
| -9% | -$51.3K | ﹤0.01% | 829 |
|
|
2020
Q2 | $601K | Sell |
3,128
-9,198
| -75% | -$1.5M | ﹤0.01% | 748 |
|
|
2020
Q1 | $1.81M | Sell |
12,326
-2,729
| -18% | -$435K | 0.01% | 423 |
|
|
2019
Q4 | $2.33M | Buy |
15,055
+8,349
| +125% | +$1.2M | 0.01% | 464 |
|
|
2019
Q3 | $906K | Buy |
6,706
+1,869
| +39% | +$245K | ﹤0.01% | 659 |
|
|
2019
Q2 | $590K | Buy |
+4,837
| New | +$536K | ﹤0.01% | 775 |
|
|
2019
Q1 | – | Sell |
-4,195
| Closed | -$478K | – | 1217 |
|
|
2018
Q4 | $478K | Sell |
4,195
-2,333
| -36% | -$250K | ﹤0.01% | 799 |
|
|
2018
Q3 | $753K | Buy |
6,528
+493
| +8% | +$54K | ﹤0.01% | 764 |
|
|
2018
Q2 | $625K | Buy |
6,035
+3,216
| +114% | +$325K | ﹤0.01% | 804 |
|
|
2018
Q1 | $278K | Buy |
+2,819
| New | +$266K | ﹤0.01% | 1012 |
|
|
2017
Q2 | – | Sell |
-10,493
| Closed | -$755K | – | 1199 |
|
|
2017
Q1 | $755K | Buy |
10,493
+848
| +9% | +$58.6K | ﹤0.01% | 642 |
|
|
2016
Q4 | $598K | Buy |
9,645
+3,413
| +55% | +$209K | ﹤0.01% | 740 |
|
|
2016
Q3 | $404K | Sell |
6,232
-1,641
| -21% | -$109K | ﹤0.01% | 781 |
|
|
2016
Q2 | $498K | Buy |
7,873
+3,304
| +72% | +$195K | ﹤0.01% | 661 |
|
|
2016
Q1 | $264K | Buy |
+4,569
| New | +$259K | ﹤0.01% | 753 |
|
Other funds holding RMD
VCM
VPM
DAM
CIBC World Market's RMD Position: Q1 2026 in Review
CIBC World Market reduced its ResMed (RMD) stake by 9.4% in Q1 2026, selling an estimated $773K and leaving 30,068 shares worth $6.75M. The position accounts for 0.01% of the portfolio, ranked #492.
CIBC World Market first reported a position in RMD in Q1 2016 and has held it in 28 quarters since. The position peaked at $12.2M in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- CIBC World Market held 30,068 shares of ResMed worth $6.75M as of Q1 2026.
- CIBC World Market sold 3,102 ResMed shares in Q1 2026, an estimated $773K.
- ResMed made up 0.01% of CIBC World Market's portfolio in Q1 2026, its #492 holding.
- CIBC World Market first reported a position in ResMed in Q1 2016 and has held it in 28 quarters since.
- CIBC World Market's ResMed position peaked at $12.2M in Q4 2024.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.